Literature DB >> 19723703

Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.

Can E Senkal1, Suriyan Ponnusamy, Jacek Bielawski, Yusuf A Hannun, Besim Ogretmen.   

Abstract

Emerging results suggest that ceramides with different fatty acid chain lengths might play distinct functions in the regulation of tumor growth and therapy. Here we report that de novo-generated C(18)- and C(16)-ceramides by ceramide synthases 1 and 6 (CerS1 and CerS6) play opposing proapoptotic and prosurvival roles, respectively, in human head and neck squamous cell carcinomas (HNSCCs). Unexpectedly, knockdown of CerS6/C(16)-ceramide using small interfering RNA induced endoplasmic reticulum (ER)-stress-mediated apoptosis. Reconstitution of C(16)-ceramide generation by induced expression of wild-type CerS6, but not its catalytically inactive mutant, protected cells from cell death induced by knockdown of CerS6. Moreover, using molecular tools coupled with analysis of sphingolipid metabolism showed that generation of C(16)-ceramide, and not dihydro-C(16)-ceramide, by induced expression of CerS6 rescued cells from ER stress and apoptosis. Mechanistically, regulation of ER-stress-induced apoptosis by CerS6/C(16)-ceramide was linked to the activation of a specific arm, ATF6/CHOP, of the unfolded protein response pathway. Notably, while expression of CerS1/C(18)-ceramide inhibited HNSCC xenograft growth, CerS6/C(16)-ceramide significantly protected ER stress, leading to enhanced tumor development and growth in vivo, consistent with their pro- and antiapoptotic roles, respectively. Thus, these data reveal an unexpected and novel prosurvival role of CerS6/C(16)-ceramide involved in the protection against ER-stress-induced apoptosis and induction of HNSCC tumor growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19723703      PMCID: PMC2797032          DOI: 10.1096/fj.09-135087

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  51 in total

1.  Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis.

Authors:  A Deniaud; O Sharaf el dein; E Maillier; D Poncet; G Kroemer; C Lemaire; C Brenner
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

2.  Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress.

Authors:  Cara A Rabik; Melissa L Fishel; Julianne L Holleran; Kristen Kasza; Mark R Kelley; Merrill J Egorin; M Eileen Dolan
Journal:  J Pharmacol Exp Ther       Date:  2008-07-29       Impact factor: 4.030

3.  Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation.

Authors:  Margaret A Park; Guo Zhang; Aditi Pandya Martin; Hossein Hamed; Clint Mitchell; Philip B Hylemon; Martin Graf; Mohamed Rahmani; Kevin Ryan; Xiang Liu; Sarah Spiegel; James Norris; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2008-10-12       Impact factor: 4.742

4.  Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate.

Authors:  Elad L Laviad; Lee Albee; Irene Pankova-Kholmyansky; Sharon Epstein; Hyejung Park; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2007-12-28       Impact factor: 5.157

5.  Calcium-independent phospholipase A2 (iPLA2 beta)-mediated ceramide generation plays a key role in the cross-talk between the endoplasmic reticulum (ER) and mitochondria during ER stress-induced insulin-secreting cell apoptosis.

Authors:  Xiaoyong Lei; Sheng Zhang; Alan Bohrer; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

6.  Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans.

Authors:  Xinzhu Deng; Xianglei Yin; Richard Allan; Diane D Lu; Carine W Maurer; Adriana Haimovitz-Friedman; Zvi Fuks; Shai Shaham; Richard Kolesnick
Journal:  Science       Date:  2008-10-03       Impact factor: 47.728

7.  Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.

Authors:  Serdar Karahatay; Kesha Thomas; Serap Koybasi; Can E Senkal; Saeed Elojeimy; Xiang Liu; Jacek Bielawski; Terry A Day; M Boyd Gillespie; Debajyoti Sinha; James S Norris; Yusuf A Hannun; Besim Ogretmen
Journal:  Cancer Lett       Date:  2007-07-09       Impact factor: 8.679

8.  ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression.

Authors:  Michael L Whitney; Leonard S Jefferson; Scot R Kimball
Journal:  Biochem Biophys Res Commun       Date:  2008-12-27       Impact factor: 3.575

9.  (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1.

Authors:  Junxia Min; Adi Mesika; Mayandi Sivaguru; Paul P Van Veldhoven; Hannah Alexander; Anthony H Futerman; Stephen Alexander
Journal:  Mol Cancer Res       Date:  2007-08       Impact factor: 5.852

10.  Trans-Golgi network and endosome dynamics connect ceramide homeostasis with regulation of the unfolded protein response and TOR signaling in yeast.

Authors:  Carl J Mousley; Kimberly Tyeryar; Kristina E Ile; Gabriel Schaaf; Renee L Brost; Charles Boone; Xueli Guan; Markus R Wenk; Vytas A Bankaitis
Journal:  Mol Biol Cell       Date:  2008-08-27       Impact factor: 4.138

View more
  128 in total

1.  A fluorescent assay for ceramide synthase activity.

Authors:  Hyun Joon Kim; Qiao Qiao; Hamish D Toop; Jonathan C Morris; Anthony S Don
Journal:  J Lipid Res       Date:  2012-06-01       Impact factor: 5.922

2.  Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.

Authors:  D Separovic; J Bielawski; J S Pierce; S Merchant; A L Tarca; G Bhatti; B Ogretmen; M Korbelik
Journal:  Int J Oncol       Date:  2010-12-06       Impact factor: 5.650

Review 3.  The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases.

Authors:  Oshrit Ben-David; Anthony H Futerman
Journal:  Neuromolecular Med       Date:  2010-05-26       Impact factor: 3.843

4.  Sphingolipids--who's controlling who in disease?

Authors:  Claudine S Bonder; Stuart M Pitson
Journal:  Immunol Cell Biol       Date:  2015-08-04       Impact factor: 5.126

Review 5.  Clinical application of ceramide in cancer treatment.

Authors:  Kazuki Moro; Masayuki Nagahashi; Emmanuel Gabriel; Kazuaki Takabe; Toshifumi Wakai
Journal:  Breast Cancer       Date:  2019-04-08       Impact factor: 4.239

6.  Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.

Authors:  Jahnabi Roy; Payam Dibaeinia; Timothy M Fan; Saurabh Sinha; Aditi Das
Journal:  J Lipid Res       Date:  2018-11-30       Impact factor: 5.922

7.  Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.

Authors:  Tejas S Tirodkar; Ping Lu; Aiping Bai; Matthew J Scheffel; Salih Gencer; Elizabeth Garrett-Mayer; Alicja Bielawska; Besim Ogretmen; Christina Voelkel-Johnson
Journal:  J Biol Chem       Date:  2015-04-03       Impact factor: 5.157

Review 8.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

Review 9.  Sphingolipids in mitochondria.

Authors:  María José Hernández-Corbacho; Mohamed F Salama; Daniel Canals; Can E Senkal; Lina M Obeid
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-09-30       Impact factor: 4.698

10.  Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.

Authors:  Laurence Booth; Nichola Cruickshanks; Seyedmehrad Tavallai; Jane L Roberts; Matthew Peery; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.